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„Sarcoidosis has many names” („Sarkoidoza 
niejedno ma imię”) the First Polish Conference 
on Sarocidosis, Ciechocinek, 25 April 2015 has 
documented this original term. The Conference 
was organized by the Clinical Diagnostic Assem-
bly of Polish Respiratory Society and the Warsaw 
Section of Polish Society of Clinical and Experi-
mental Immunology. The importance of this event 
was supported by the participation of leading 
Polish experts in sarcoidosis and a large audience 
including 70 medical doctors and 30 patients from 
the „Sarco-Association”. All participants pointed 
to the urgent need to prepare national guidelines 
for the diagnosis, management and treatment of 
sarcoidosis. 
The first lectures focused on recent advances 
in the treatment of this disease (prof. D. Ziora, 
prof. T. Płusa, dr M. Piotrowska). The theoretical 
background of treatment, the international guide-
lines and the indication for lung transplantation 
were presented. Recent progress in the treatment 
of sarcoidosis seems to copy biological and per-
sonalized regimens used in the other diseases. 
The need for approval for the use of anti- TNFa 
in Poland was emphasized. 
In the next part of the clinical session the 
role of diagnostic methods was presented. As-
soc. Prof. W. Piotrowski referred to inadequate 
use of HRCT in the management of sarcoidosis. 
Assoc. Prof. T. Przybyłowski in his comprehen-
sive lecture emphasized the role of pulmonary 
function tests and exercise tests in the diagnosis 
and management of this disease. The value of 
the detection of obstruction in pulmonary func-
tion tests, appropriate interpretation of diffusing 
capacity measurement, and the indication to 
exercise tests were discussed. In the next pre-
sentations it was pointed out that in most cases 
histopathological confirmation of sarcoidosis 
is needed. Prof. R. Krenke, dr Ł. Kasper, and 
dr M. Jakubiak presented the role of modern en-
doscopic techniques and cytological methods as 
diagnostic procedures. Particular attention was 
given to the new possibility of cytological samples 
processing by the use of cell blocks. 
Diagnosis and treatment of extrapulmonary 
sarcoidosis remains controversial. Sarcoidosis of 
the nervous system was discussed by pulmonolo-
gist dr A. Kempisty and also by neurologist Assoc. 
Prof. M. Gaweł. These two lectures were follo-
wed by the presentation of muscular sarcoidosis 
by dr. M. Lipowska. These three presentations 
showed the importance of appropriate and quick 
diagnosis of the involvement of the nervous system 
by granulomas and the need for intensive treat-
ment as nervous system sarcoidosis may be fatal. 
Regarding the etiopathogenesis of sarcoido-
sis, prof. A. Dubaniewicz revealed the latest re-
sults of molecular studies on the role of receptors 
FcgR, encoded by polymorphic FCGRI-III genes, 
in the context of ‘danger theory’. The recently 
discovered complicated molecular mechanisms 
of the immune reactions were discussed by prof. 
J. Malejczyk and dr. E. Gładkowska- Mrówka. All 
speakers indicated the possible etiological role of 
microbes in sarcoidosis. Assoc. Prof. B. Szponar 
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presented a recent view on the role of lung micro-
biom and dr A. Kempisty initiated a discussion 
on the role of the detection of latent tuberculosis 
in the course of sarcoidosis. 
Tobacco smoking is the main risk factor in 
most lung diseases. In sarcoidosis the suggested 
protective role of nicotine has been investigated 
for many years without any evidence in support. 
The debate in this field was conducted by prof. 
J. Domagała-Kulawik and dr E. Puscinska (pro and 
contra). 
During the third part of the conference the 
results of original studies were presented and 
discussed by the authors. 
It should be mentioned that uniquely not 
only medical doctors but also patients suffering 
from sarcoidosis participated in this conference. 
They directed many questions to the experts and 
received many useful clarifications regarding this 
life-long disease.
The First Polish Conference will not be the last 
meeting devoted to such a mysterious disease. Prof. 
A. Dubaniewicz is pleased to announce the next 
WASOG Meeting in Gdańsk, on 3−4th June 2016. 
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